USOR - Texas Oncology Northeast Texas - Denison — Denison, Texas

USOR - Texas Oncology Northeast Texas - Denison is a clinical research site located in Denison, Texas, United States 75020.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

USOR - Texas Oncology Northeast Texas - Denison has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Advanced or Metastatic Solid Malignancies.

Sponsors: Mirati Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denison

Browse all research sites in Texas · View every site in Denison

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USOR - Texas Oncology Northeast Texas - Denison?

USOR - Texas Oncology Northeast Texas - Denison has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USOR - Texas Oncology Northeast Texas - Denison conducted?

USOR - Texas Oncology Northeast Texas - Denison has 3 clinical trials on record, with 1 currently active. Their work covers Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Advanced or Metastatic Solid Malignancies.

Is USOR - Texas Oncology Northeast Texas - Denison accredited by Crixeo Clinical Trials?

USOR - Texas Oncology Northeast Texas - Denison has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USOR - Texas Oncology Northeast Texas - Denison?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.